Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DMR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,917
Award facts
- Contract value 100% obligated
- $10,916.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.58 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s substantial indefinite delivery contract with DLA Troop Support Medical valued at up to $999.999 billion through December 2031, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement through its extensive portfolio of federal medical supply contracts and demonstrated capability to deliver a wide spectrum of pharmaceutical products including specialty medications and branded drugs. This delivery order for Dupixent, a prescription immunosuppressant medication used in treating various inflammatory conditions, exemplifies the company's critical role in supporting military healthcare operations and other federal medical institutions through efficient and reliable pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26F9DMR?
SPE2DR26F9DMR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9DMR worth?
The government has obligated $10,917 on SPE2DR26F9DMR.
Is contract SPE2DR26F9DMR an order under another contract?
Yes. SPE2DR26F9DMR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DMR competed?
The extent of competition for SPE2DR26F9DMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award